Safety and Biomarker Study of PTC-589 in Participants With Parkinson's Disease
Clinical trial NCT02462603 · COMPLETED
Trial details
- NCT number
- NCT02462603
- Sponsor
- Edison Pharmaceuticals Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-17
- Primary completion
- 2019-01-08
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.